Shenzhen Neptunus Interlong Bio-Tech

Shenzhen Neptunus Interlong Bio-Tech is a company listed under the stock ticker 000078 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Shenzhen Neptunus Interlong Bio-Tech

• Feng Zhang, Executive Chairman of the Board and Compliance Officer
• Ka Yeung Poon, Independent Non-Executive Director
• Yifei Zhang, Non-Executive Director

Create your alert
to follow the executive moves at Shenzhen Neptunus Interlong Bio-Tech.

Shenzhen Neptunus Interlong Bio-Tech has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Shenzhen Neptunus Interlong Bio-Tech

Social media about Shenzhen Neptunus Interlong Bio-Tech

• Shenzhen Neptunus Interlong Bio-Tech on Wikipedia, Google News & Yahoo Finance
• Shenzhen Neptunus Interlong Bio-Tech on LinkedIn, Twitter & YouTube

Contact by email its executives including Feng Zhang

Call Shenzhen Neptunus Interlong Bio-Tech at +86 755 ...

View the org chart

Register to receive your alert

Report an error